Gregory Alvarez, DPM
Foot & Ankle Surgery · Fayetteville, GANPI 1861496754
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $10,027 of the $11,981 with a category attached, or 83.7%. Fuse Medical, Inc. accounts for 83.7% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2023 at $3,908 and has fallen 81.5% since, to $721 in 2025.
Across 74 payments — averaging $161.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fuse Medical, Inc.$10K
- Treace Medical Concepts, Inc.$1K
- Nevro Corp.$195
- Medtronic$166
- Polarityte, Inc.$85
- Trilliant Surgical LLC.$78
- plus $375 from 16 others
What the payments were for
- Royalty or licence$10,02784%
- Food & beverage$1,95416%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fuse Medical, Inc. | 4 | $10,027 |
| Treace Medical Concepts, Inc. | 40 | $1,056 |
| Nevro Corp. | 3 | $195 |
| Medtronic | 3 | $166 |
| Polarityte, Inc. | 2 | $85 |
| Trilliant Surgical LLC. | 1 | $78 |
| Amgen | 3 | $47 |
| Bioventus LLC | 2 | $45 |
| Stimwave Technologies Incorporated | 2 | $35 |
| Organogenesis Inc. | 1 | $32 |
| Hikma Pharmaceuticals USA | 2 | $31 |
| Stryker | 1 | $31 |
| GRT US Holding, Inc. | 1 | $25 |
| Abbott | 1 | $21 |
| Solventum Corporation | 1 | $19 |
| Integra Lifesciences Corporation | 1 | $18 |
| Reprise Biomedical, Inc. | 1 | $15 |
| Kerecis Limited | 1 | $14 |
| Zimmer Biomet | 1 | $12 |
| Nabriva Therapeutics, PLC | 1 | $12 |
| Merck | 1 | $11 |
| Dynasplint Systems Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orbitum Staple System$6,493
- Orbitum Staple$3,534
- Omnia$146
- ClosureFast$133
How this compares
$11,981 in reported general payments places this provider in the 85th percentile of 239 foot & ankle surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Colchicine | 40 | $1,037 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 68 | $564 |
| Ibuprofen | 84 | $497 |
| Clobetasol Propionate | 13 | $398 |
| Terbinafine Hcl | 46 | $356 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 47 | $289 |
| Doxycycline Hyclate | 29 | $216 |
| Ciprofloxacin Hcl | 21 | $216 |
| Cephalexin | 40 | $163 |
| Methylprednisolone | 24 | $128 |
| IbuIbuprofen | 21 | $81 |
| Tramadol Hcl | 14 | $67 |
| Meloxicam | 12 | $63 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $55 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Fayetteville
- Robert WeinsteinFayetteville$394K
- Jason BariteauAtlanta$199K
- Scott RomanPeachtree City$118K
- Jeffrey FlashForest Park$114K
- Mickey StappThomson$110K
- David MurphyWaycross$55K
- Rishin KadakiaAtlanta$53K
- Javan BassLithonia$43K
- Bhavin MehtaAtlanta$43K
- Corbett ThigpenAugusta$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.